IRIS
ROVIELLO, FRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.123
EU - Europa 19.426
AS - Asia 3.326
AF - Africa 130
SA - Sud America 47
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 22
Totale 46.111
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.071
GB - Regno Unito 5.972
IE - Irlanda 3.902
CN - Cina 2.534
UA - Ucraina 2.241
SE - Svezia 1.916
IT - Italia 1.447
FR - Francia 1.270
DE - Germania 984
RU - Federazione Russa 611
FI - Finlandia 599
SG - Singapore 357
ES - Italia 172
VN - Vietnam 152
BE - Belgio 90
CI - Costa d'Avorio 78
IN - India 59
TR - Turchia 47
CA - Canada 44
IR - Iran 42
RO - Romania 32
NL - Olanda 31
AU - Australia 30
MU - Mauritius 26
PT - Portogallo 23
BR - Brasile 21
EU - Europa 21
CZ - Repubblica Ceca 20
EG - Egitto 20
JP - Giappone 20
PL - Polonia 15
HK - Hong Kong 13
GR - Grecia 11
PH - Filippine 11
SA - Arabia Saudita 11
SI - Slovenia 11
KR - Corea 10
BG - Bulgaria 9
AT - Austria 8
IL - Israele 8
NZ - Nuova Zelanda 7
CH - Svizzera 6
CL - Cile 6
DK - Danimarca 6
HU - Ungheria 6
MY - Malesia 6
AL - Albania 5
AZ - Azerbaigian 5
EC - Ecuador 5
KG - Kirghizistan 5
LK - Sri Lanka 5
LU - Lussemburgo 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
AR - Argentina 4
EE - Estonia 4
ET - Etiopia 4
ID - Indonesia 4
KZ - Kazakistan 4
LV - Lettonia 4
MD - Moldavia 4
PE - Perù 4
PK - Pakistan 4
TH - Thailandia 4
BD - Bangladesh 3
CY - Cipro 3
IM - Isola di Man 3
JO - Giordania 3
MX - Messico 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
BO - Bolivia 2
GE - Georgia 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LC - Santa Lucia 2
PA - Panama 2
TW - Taiwan 2
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CM - Camerun 1
CO - Colombia 1
FK - Isole Falkland (Malvinas) 1
IQ - Iraq 1
JM - Giamaica 1
KH - Cambogia 1
LI - Liechtenstein 1
LT - Lituania 1
MA - Marocco 1
MC - Monaco 1
MK - Macedonia 1
OM - Oman 1
TM - Turkmenistan 1
UZ - Uzbekistan 1
Totale 46.111
Salva come PNG Salva come JPEG
Città #
Southend 5.610
Fairfield 3.928
Dublin 3.875
Chandler 2.036
Jacksonville 1.928
Ashburn 1.776
Woodbridge 1.759
Wilmington 1.461
Seattle 1.426
Houston 1.363
Cambridge 1.281
Ann Arbor 966
Princeton 758
Nanjing 617
Beijing 442
Siena 392
Boardman 300
San Mateo 297
Helsinki 224
New York 223
San Diego 210
Singapore 207
Nanchang 196
Shanghai 181
Shenyang 167
Málaga 162
Moscow 151
Dong Ket 144
Hebei 118
Tianjin 117
Menlo Park 87
Brussels 85
Jiaxing 85
Changsha 84
Abidjan 78
Kunming 77
Düsseldorf 71
Florence 71
London 62
Norwalk 60
Dearborn 58
Jinan 56
Ningbo 50
Falls Church 49
Venezia 48
Rome 45
San Francisco 42
Zhengzhou 40
Washington 38
Milan 37
Guangzhou 34
Hangzhou 34
Lappeenranta 33
Dallas 32
Höst 28
Redwood City 28
Fremont 27
Port Louis 26
Toronto 26
Izmir 25
Tappahannock 25
Los Angeles 24
Taizhou 23
Lanzhou 21
Changchun 20
Kilburn 17
Hounslow 16
Phoenix 16
Brno 15
Leawood 14
Porto 14
Serra 14
Bologna 13
Munich 13
Sacramento 13
Andover 12
Genoa 12
Tokyo 12
Verona 12
Atlanta 11
Canberra 11
Chicago 11
Indiana 11
Melbourne 11
Viareggio 11
Zanjan 11
Bangalore 10
Mestre 10
Riyadh 10
Tehran 10
Berlin 9
Detroit 9
Fuzhou 9
Redmond 9
Amsterdam 8
Arezzo 8
Cairo 8
Delhi 8
Trento 8
Vienna 8
Totale 34.338
Salva come PNG Salva come JPEG
Nome #
Gastric cancer maximum tumour diameter reduction rate at CT examination as a radiological index for predicting histopathological regression after neoadjuvant treatment: A multicentre GIRCG study 217
Pluripotency regulators in human mesenchymal stem cells: expression of NANOG but not of OCT-4 and SOX-2 200
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer 196
Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) 193
C-Met targeting in advanced gastric cancer: An open challenge 191
354. KRAS mutation in gastric cancer- molecular, and clinico-pathological characteristic 185
Clinical significance of multifocal and multicentric breast cancers and choice of surgical treatment: a retrospective study on a series of 1158 cases 182
Nipple-areola complex reconstruction techniques: A literature review 182
Familial aggregation of gastric cancer with microsatellite instability** 180
65. Molecular surgery for gastric cancer-role of microsatellite instability in elderly patients 177
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives 176
Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer 174
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer 173
Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study 172
Robotic versus laparoscopic gastrectomy for gastric cancer: protocol for umbrella review of systematic reviews and meta-analyses 169
KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status 168
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer 167
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer 166
611. Gastric cancer patients with familial aggregation of gastric cancer and Lynch syndrome associated cancers with microsatellite instability 166
Recurrence after surgery in esophago-gastric junction adenocarcinoma: Current management and future perspectives 166
Comparison between 7th and 8th edition of AJCC TNM staging system for gastric cancer: Old problems and new perspectives 165
From digital world to real life: A robotic approach to the esophagogastric junction with a 3D printed model 164
E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. 163
613. Lymph node metastases in microsatellite unstable gastric cancer 163
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 163
Il ruolo della chemioipertermia nel carcinoma del colon-retto 162
E-cadherin germline mutation carriers: clinical management and genetic implications 162
Clinical evaluation of the Mannheim Prognostic Index in post-operative peritonitis: a prospective cohort study 162
Naso-gastric or naso-jejunal decompression after partial distal gastrectomy for gastric cancer. Final results of a multicenter prospective randomized trial 161
353. PIK3CA mutation in gastric cancer and the role of different codon mutations in the new molecular division of that neoplasm 161
Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer 161
610. Heterogeneity of new molecular gastric cancer classifications. Clinico-pathological characteristic 161
612. Molecular background of high risk and low risk areas of gastric cancer in Italy 160
Trattamento chirurgico radicale di emangiopericitoma retroperitoneale recidivo: case report. 160
530. Minimally invasive surgery for the treatment of colo-rectal adenocarcinoma: Laparoscopic and robotic approach 159
Molecular key to understand the gastric cancer biology in elderly patients—The role of microsatellite instability 157
The pattern of lymph node metastases in microsatellite unstable gastric cancer 156
Re-evaluation of Mannheim prognostic index in perforative peritonitis: Prognostic role of advanced age. A prospective cohort study 156
Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer 155
Family history of gastric cancer: a correlation between epidemiologic findings and clinical data 155
338. Comparing characteristics and survival outcomes of adolescent and young adults to mature patients with colorectal cancer 155
Vitamin E serum levels and gastric cancer: results from a cohort of patients in Tuscany, Italy 154
Gastric Cancer and Synchronous Hepatic Metastases: Is It Possible to Recognize Candidates to R0 Resection? 154
Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an italian family 154
HERG1 channels regulate VEGF-A secretion in human gastric cancer: Clinicopathological correlations and therapeutical implications 153
Clinical impact of molecular classifications in gastric cancer 153
Gastric stump carcinoma after distal subtotal gastrectomy for early gastric cancer: Experience of 541 patients with long-term follow-up 153
CA 19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions 153
Number of lymph nodes assessed has no prognostic impact in node-negative rectal cancers after neoadjuvant therapy. Results of the “Italian Society of Surgical Oncology (S.I.C.O.) Colorectal Cancer Network” (SICO-CCN) multicentre collaborative study 151
Long-term outcomes in ypT0 rectal cancers: An international multi-centric investigation on behalf of Italian Society of Surgical Oncology Young Board (YSICO) 151
Duodenal gastrointestinal stromal tumor: From clinicopathological features to surgical outcomes 150
A new way to experience the International Gastric Cancer Association Congress: the Web Round Tables 149
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer 149
External Validation of a Score Predictive of Recurrence after Radical Surgery for Non-Cardia Gastric Cancer: Results of a Follow-Up Study 149
High-risk and low-risk gastric cancer areas in Italy and its association with microsatellite instability 148
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study 146
null 146
E-cadherin and hereditary diffuse gastric cancer. 145
CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab 145
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience 145
Trans-pericardal Color Doppler Ultra Sound to Assess Blood Flow in the Visceral Branches during Type A Dissection Procedures Complicated with Mesenteric Malperfusion 145
Clinical and oncological value of preoperative BMI in gastric cancer patients: A single center experience 144
International consensus on a complications list after gastrectomy for cancer 144
Complications after surgery for gastric cancer in patients aged 80 years and over 144
Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer 142
Western perspective and epidemiology of gastric cancer 142
Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments. 142
Robotic single docking total colectomy for ulcerative colitis: First experience with a novel technique 141
Potential impact of molecular classification on tailored lymphadenectomy for gastric cancer 141
Elastofibroma dorsi: three cases of personal experience 141
Primary non-Hodgkin's breast lymphoma: surgical approach. 141
K-RAS mutation in gastric cancer and its link with microsatellite instability status 141
Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project 140
Breast cancer local recurrence: risk factors and prognostic relevance of early time to recurrence 140
PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene 140
Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results 139
High accuracy of multislices computed tomography (MSCT) for para-aortic lymph node metastases from gastric cancer: a prospective single-center study. 139
28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis 139
Gastro-pleuro-pericardial fistula following combined radiation and chemotherapy for lung metastases from renal cell carcinoma: report of a case 138
Assessment of Microsatellite Instability in Familial Gastric Cancer 138
Robot-assisted laparoscopic gastrectomy for gastric cancer 138
Super-extended (D3) lymphadenectomy in advanced gastric cancer. 137
Surgical treatment of gastric cancer in Latvia: results of centralized experience. 137
Factors influencing survival after hepatectomy for metastases from gastric cancer 137
Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer 137
A rare case of primary small bowel adenocarcinoma with intussusception. 136
Gemcitabine increases systemic 5-fluorouracil exposure in advanced cancer patients. 136
Cell proliferation, cell death and angiogenesis in early and advanced gastric cancer of intestinal type 136
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 136
Krukenberg Tumors of Gastric Origin: The Rationale of Surgical Resection and Perioperative Treatments in a Multicenter Western Experience 136
Targeting VEGFR-2 in Metastatic Gastric Cancer: Results From a Literature-Based Meta-Analysis 136
A clinical case of duodenal gastrointestinal stromal tumor with a peculiarity in the surgical approach. 136
Accuracy of transrectal ultrasound after preoperative radiochemotherapy compared to computed tomography and magnetic resonance in locally advanced rectal cancer. 136
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference 136
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer 136
Gastric stump cancer after distal gastrectomy for benign disease: Clinicopathological features and surgical outcomes 135
High incidence of familial gastric cancer in Tuscany, a region in Italy. 135
Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer 134
Presacral ganglioneuroma: a case report and review of literature 134
Laparoscopic and robot-assisted gastrectomy for gastric cancer: Current considerations 134
Totale 15.348
Salva come PNG Salva come JPEG
Categoria #
all - tutte 154.940
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 154.940
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.628 0 0 796 1.613 599 730 798 1.325 883 849 380 655
2020/20217.476 284 910 226 795 299 854 288 1.118 917 588 618 579
2021/20225.456 458 686 364 383 259 204 252 187 318 564 586 1.195
2022/20237.636 470 463 1.064 1.078 745 1.679 169 568 773 227 220 180
2023/20245.479 286 155 445 202 173 1.545 2.000 76 21 175 57 344
2024/2025954 307 647 0 0 0 0 0 0 0 0 0 0
Totale 46.669